Next Article in Journal
Consequences of Lamin B1 and Lamin B Receptor Downregulation in Senescence
Previous Article in Journal
Identification of Novel Hemangioblast Genes in the Early Chick Embryo
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4+ T-Cells

Department of Molecular Diagnostic and Epidemiology, Federal Budget Institution of Science “Central Research Institute of Epidemiology” of The Federal Service on Customers’ Rights Protection and Human Well-being Surveillance, 111123 Moscow, Russia
*
Author to whom correspondence should be addressed.
Cells 2018, 7(2), 10; https://doi.org/10.3390/cells7020010
Submission received: 15 December 2017 / Revised: 18 January 2018 / Accepted: 2 February 2018 / Published: 4 February 2018

Abstract

C-C chemokine receptor type 5 (CCR5) is utilized by human immunodeficiency virus (HIV) as a co-receptor for cell entry. Suppression of the CCR5 gene by artificial microRNAs (amiRNAs) could confer cell resistance. In previous work, we created a lentivector that encoded the polycistron of two identical amiRNAs that could effectively suppress CCR5. However, tandem repeats in lentiviral vectors led to deletions of the repeated sequences during reverse transcription of the vector RNA. To solve this problem, we have created a new amiRNA against CCR5, mic1002, which has a different microRNA scaffold and targets a different sequence. Replacing one of the two identical tandem amiRNAs in the polycistron with the mic1002 amiRNA increased the accuracy of its lentiviral vector transfer while retaining its ability to effectively suppress CCR5. A lentiviral vector containing two heterogenic amiRNAs significantly inhibited HIV replication in a vector-transduced human CD4+ lymphocyte culture.
Keywords: HIV gene therapy; CCR5 co-receptor; RNA interference; miRNA; lentiviral vectors HIV gene therapy; CCR5 co-receptor; RNA interference; miRNA; lentiviral vectors

Share and Cite

MDPI and ACS Style

Urusov, F.; Glazkova, D.; Omelchenko, D.; Bogoslovskaya, E.; Tsyganova, G.; Kersting, K.; Shipulin, G.; Pokrovsky, V. Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4+ T-Cells. Cells 2018, 7, 10. https://doi.org/10.3390/cells7020010

AMA Style

Urusov F, Glazkova D, Omelchenko D, Bogoslovskaya E, Tsyganova G, Kersting K, Shipulin G, Pokrovsky V. Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4+ T-Cells. Cells. 2018; 7(2):10. https://doi.org/10.3390/cells7020010

Chicago/Turabian Style

Urusov, Felix, Dina Glazkova, Denis Omelchenko, Elena Bogoslovskaya, Galina Tsyganova, Katerina Kersting, German Shipulin, and Vadim Pokrovsky. 2018. "Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4+ T-Cells" Cells 7, no. 2: 10. https://doi.org/10.3390/cells7020010

APA Style

Urusov, F., Glazkova, D., Omelchenko, D., Bogoslovskaya, E., Tsyganova, G., Kersting, K., Shipulin, G., & Pokrovsky, V. (2018). Optimization of Polycistronic Anti-CCR5 Artificial microRNA Leads to Improved Accuracy of Its Lentiviral Vector Transfer and More Potent Inhibition of HIV-1 in CD4+ T-Cells. Cells, 7(2), 10. https://doi.org/10.3390/cells7020010

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop